Table 4.
VTE | No VTE | p-valuea | |||
---|---|---|---|---|---|
Mean (SD) | Median | Mean (SD) | Median | ||
Utilization | |||||
Inpatient Admissions (n) | 2.47 (1.75) | 2 | 0.62 (0.95) | 0 | <0.0001 |
Length of Stay (Days) | 62.06 (72.32) | 29 | 5.89 (21.06) | 0 | <0.0001 |
Outpatient Visits (n) | 30.65 (25.55) | 26 | 11.30 (12.72) | 8 | <0.0001 |
Pharmaceutical Claims (n) | 18.92 (17.65) | 16 | 5.82 (8.14) | 3 | <0.0001 |
Expenditures (USD) | |||||
Inpatient Admissions | $307,328 (540,769) | $79,027 | $18,147 (85,891) | $0 | <0.0001 |
Outpatient Visits | $27,511 (55,731) | $14,675 | $6,476 (17,126) | $2,951 | <0.0001 |
Pharmaceutical Claims | $3,499 (7,502) | $702 | $548 (2,702) | $49 | <0.0001 |
Total Expenditures | $338,338 (544,045) | $126,708 | $25,171 (90,792) | $5,332 | <0.0001 |
Wilcoxon rank sum test